Document is current
Any future updates will be listed below
-
Authors
Hernández-Pérez, Jesus Gibran https://orcid.org/0000-0002-7637-4127
Abdelgadir, Omer
Jang, Subin
Ernest, Deepali K.
Zhang, Xiaotao
Shah, Dimpy
Hong, Arthur S.
Almandoz, Jaime P.
Cowell, Lindsay G.
Messiah, Sarah E.
Lopez, David S.
-
Funding
Funding for this research was provided by:
National Cancer Institute (P30CA142543)
Cancer Prevention and Research Institute of Texas (RP210130)
National Institute of Diabetes and Digestive and Kidney Diseases (P30DK127984)
National Center for Advancing Translational Sciences (UL1TR003163)
Patient-Centered Outcomes Research Institute (RI-MISSOURI-01-PS8)
- License Information
-
More Information
Article History
Received: 24 May 2026
Accepted: 25 July 2026
First Online: 12 August 2026
Declarations
Conflict of interest: Jesus Gibran Hernández-Pérez, Omer Abdelgadir, Subin Jang, Deepali K. Ernest, Xiaotao Zhang, Dimpy Shah, Arthur S. Hong, Jaime P. Almandoz, Lindsay G. Cowell, Sarah E. Messiah and David S. Lopez have declares no conflicts of interest.
Ethical approval: The research followed ethical standards set forth in the Declaration of Helsinki and received approval from the Institutional Review Board of the University of Texas Southwestern Medical Center in Dallas, Texas, USA (IRB# STU122016-009; Approval date January 27, 2017).
Consent to participate: This secondary analysis did not constitute human subjects research, as it was conducted using pre-existing data that had been de-identified and therefore was exempt form informed consent requirements.
